CSI Market
Sign In | Register

Medpace Holdings Inc (MEDP) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access MEDP quarterly Cash Flow →
Quarterly cash flow trends provide additional context on Medpace Holdings Inc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income451.12
Depreciation & amortization27.18
Amortization of Other Assets0.95
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation34.79
Income (Loss) from Equity Method Investments0.00
Increase (Decrease) in Restricted Cash for Operating Activities0.00
Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost-
Increase Decrease In Pre Funded Study Costs-
Non Cash Lease Expense-
Increase Decrease In Contract With Customer Liability143.81
Operating Lease Right Of Use Asset Amortization Expense23.01
Income taxes80.77
Losses/ -gains on Investments net0.00
Increase (Decrease) in Receivables-106.22
Increase (Decrease) in Accounts Payable2.63
Increase (Decrease) in Accrued Liabilities97.08
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-27.10
Other Working Capital11.24
Other Noncash Income (Expense)-0.88
Other net0.00
Payments for (Proceeds from) Other Operating Activities-25.16
Discontinued operations0.00
Net Cash flow from Operating Activities713.22
Investing Activities
Capital Expenditures-31.36
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments To Acquire Businesses Net Of Cash And Restricted Cash Acquired-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.22
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-31.14
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-860.39
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-669.44
Cash And Cash Equivalents And Restricted Cash At Carrying Value-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents669.44
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-860.39
Effect of exchange rate on cash flow5.92
Discontinued operations0.00
Free Cash Flow681.87
Total Cash Flow-172.39
4 historic quarters locked

Sign in to unlock the full Medpace Holdings Inc cash flow history.

Sign In Create Free Account

About Medpace Holdings Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 10, 2026
  • Source: medp-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001668397-26-000006

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License